Treatment Effectiveness
User reported effectiveness ratings Naproxen (Aleve) for various conditions.
| Conditions | Major Improvement | Moderate Improvement | Much Worse | No Effect | Worse | Responses |
|---|---|---|---|---|---|---|
| Arthritis | 4% | 41% | 0% | 48% | 7% | 71 |
| Chronic Fatigue Syndrome | 3% | 30% | 5% | 54% | 8% | 131 |
| Endometriosis | 3% | 32% | 5% | 55% | 6% | 181 |
| Lower Back Pain | 5% | 50% | 3% | 40% | 2% | 121 |
| Migraine | 3% | 26% | 4% | 61% | 6% | 700 |
| Peripheral Neuropathy | 6% | 18% | 0% | 71% | 6% | 17 |
| Premenstrual Syndrome (PMS) | 31% | 31% | 8% | 23% | 8% | 13 |
| Rheumatoid Arthritis | 3% | 41% | 3% | 48% | 3% | 58 |
Side Effects
User-reported side effects of Naproxen (Aleve)
| Side Effect | Percent of Reports Naproxen (Aleve) |
|---|---|
| Diarrhea | 9% |
| Constipation | 16% |
| Bleeding Duodenum to Rectum | 4% |
| Burning or Tingling in the Arms or Legs | 9% |
| Cold Symptoms | 7% |
| Difficulty Falling Asleep or Staying Asleep | 14% |
| Dizziness | 9% |
| Drowsiness | 10% |
| Dry Skin | 12% |
| Elevated Intracranial Pressure | 4% |
| Excessive Thirst | 14% |
| Hearing Problems | 5% |
| Increased Cranial Pressure | 4% |
| Kidney Dis-Function | 10% |
| Lightheadedness | 10% |
| Ringing in the Ears | 15% |
| Severe Bruising | 14% |
| Sores in Mouth | 6% |
| Headache | 8% |
| Gas | 15% |
Outcomes
Below is the degree of change seen after Naproxen (Aleve) is higher than average.
|
|
Outcomes Label
Naproxen (Aleve) Info
| Property | Value |
|---|---|
| Variable Name | Naproxen (Aleve) |
| Aggregation Method | SUM |
| Analysis Performed At | 2020-03-24 |
| Duration of Action | 21 days |
| Filling Value | 0 |
| Minimum Allowed Value | 0 count |
| Number of Aggregate Predictors | 0 |
| Number of Aggregate Outcomes | 0 |
| Number of Measurements | 0 |
| Number of Measurements (including those generated by tagged, joined, or child variables) | 0 |
| Public | true |
| Onset Delay | 30 minutes |
| Unit | Count |
| User Variables | 0 |
| Variable Category | Treatments |
| Variable ID | 94503 |